WORLD FDA OKs 3rd dose of COVID-19 vaccines for immunocompromised people

WORLD

FDA OKs 3rd dose of COVID-19 vaccines for immunocompromised people

Xinhua

14:26, August 13, 2021

WASHINGTON, Aug. 12 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday authorized third doses of COVID-19 vaccines for people with weakened immune systems.

A health care worker prepares a dose of COVID-19 vaccine at a new vaccination site in the California Polytechnic State University in Pomona, Los Angeles County, California, the United States, Feb. 5, 2021. (Xinhua)

"The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease," Acting FDA Commissioner Janet Woodcock said in a statement.

"After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines," Woodcock added.

"The FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose may be needed in the future," Woodcock said.

An estimated 2.7 percent of adults in the United States are immunocompromised, according to the Centers for Disease Control and Prevention. That includes organ transplant recipients, certain cancer patients and people with HIV.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue